Zobrazeno 1 - 10
of 17
pro vyhledávání: '"G N, Ranzani"'
Autor:
A L, Scovassi, N S, Pellegata, L, Di Stefano, L, Padovan, C, Negri, E, Prosperi, F, Riva, M, Ciomei, G N, Ranzani
Publikováno v:
Anticancer research. 21(4A)
Gastric cancer is poorly-responsive to widely used antitumour drugs, the efficacy of which is thought to be related to the capacity of triggering apoptosis. This process requires a series of gene products including a functional p53 protein. We tested
Autor:
P, Tenti, N, Vesentini, M, Rondo Spaudo, R, Zappatore, P, Migliora, L, Carnevali, G N, Ranzani
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 9(4)
A case-control study was performed to investigate the risk of cervical cancer associated with p53 polymorphism at codon 72, encoding either arginine or proline. It has been recently suggested that the arginine isoform increases the susceptibility to
Autor:
I, Rudan, H, Campbell, G N, Ranzani, M, Strnad, A, Vorko-Jović, V, John, J, Kern, D, Ivanković, R, Stevanović, S, Vuckov, S, Vuletić, P, Rudan
Publikováno v:
Collegium antropologicum. 23(2)
As an extension of previous research this study investigates the incidence of cancer in five genetic isolate island populations of the Eastern Adriatic, Croatia. Thorough anthropological research over the past three decades has established some of th
Autor:
I, Rudan, G N, Ranzani, M, Strnad, A, Vorko-Jović, V, John, J, Unusić, J, Kern, D, Ivanković, R, Stevanović, S, Vuletić, P, Rudan
Publikováno v:
Collegium antropologicum. 23(2)
The aim of this study was to analyze whether there are surnames which appear more frequently among the ancestors of cancer cases in a small isolate, in comparison to the ancestral surnames of the healthy controls, using the classic case-control desig
Publikováno v:
European journal of histochemistry : EJH.
We investigated a series of clinically well documented pancreatic ductal adenocarcinomas for the presence of molecular alterations of the p53 and Ki-ras genes and their correlations with p53 nuclear immunohistochemical expression. The results were ev
Autor:
N S, Pellegata, G N, Ranzani
Publikováno v:
European journal of histochemistry : EJH. 40(4)
Autor:
G N, Ranzani, O, Luinetti, L S, Padovan, D, Calistri, B, Renault, M, Burrel, D, Amadori, R, Fiocca, E, Solcia
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 4(3)
We screened for p53 alterations in 71 early gastric cancers of differing histological types and growth patterns, 18 advanced cancers of diffuse type, 19 dysplastic lesions, and 12 extensive intestinal metaplasia cases. Tumors were investigated for ge
Publikováno v:
Cancer research. 54(6)
We studied K-ras and p53 gene mutations in a panel of 57 primary pancreatic cancers including ductal and nonductal tumors. DNAs were obtained from formalin-fixed, paraffin-embedded material. Target sequences were amplified by polymerase chain reactio
Autor:
B, Renault, M, van den Broek, R, Fodde, J, Wijnen, N S, Pellegata, D, Amadori, P M, Khan, G N, Ranzani
Publikováno v:
Cancer research. 53(11)
We searched for P53 mutations in gastric carcinoma by analyzing tumor DNAs from 29 patients. We detected 13 different somatic mutations in 15 patients (52%) and a biallelic polymorphism in exon 6 (5 heterozygous subjects). The somatic mutations were
Autor:
N S, Pellegata, M, Losekoot, R, Fodde, V, Pugliese, S, Saccomanno, B, Renault, L F, Bernini, G N, Ranzani
Publikováno v:
Anticancer research. 12(5)
In pancreatic neoplasias mutations in the first exon (codon 12) of K-ras gene occur at high frequency and seem to have a diagnostic significance. We set up the DGGE conditions to search for these mutations in pancreatic tumor sample DNAs. All samples